Burning Rock Biotech Share Price Today
(NASDAQ: BNR)

Name: Burning Rock Biotech Share Price Today (NASDAQ: BNR) - Burning Rock Biotech Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Burning Rock Biotech share price is $5.54 & ₹481.81 as on 6 Mar 2025, 2.30 'hrs' IST

$5.54

▲

0.32

(6.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Burning Rock Biotech share price in Dollar and Rupees. Guide to invest in Burning Rock Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Burning Rock Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Burning Rock Biotech share price movements

Today's Low: $5.22
Today's High: $5.54
$5.54
5.77%
Downside
Day's Volatility :5.82%
Upside
0.05%
52 Weeks Low: $2.62
52 Weeks High: $8.99
$5.54
52.71%
Downside
52 Weeks Volatility :70.86%
Upside
38.38%

Burning Rock Biotech (BNR) Returns

Period	Burning Rock Biotech Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	-24.84%	2.1%	0.0%
6 Months	11.12%	-4.1%	0.0%
1 Year	-34.7%	2.2%	0.0%
3 Years	-92.75%	11.8%	-11.6%

Burning Rock Biotech (BNR) Key Statistics

in dollars & INR

Previous Close	$5.2238
Open	$5.2201
Today's High	$5.5429
Today's Low	$5.2201
Market Capitalization	$61.7M
Today's Volume	$708.0
52 Week High	$8.99
52 Week Low	$2.62
Revenue TTM	$510.9M
EBITDA	$-302.5M
Earnings Per Share (EPS)	$-5.73
Profit Margin	-83.69%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-56.59%

How to invest in Burning Rock Biotech Stock (BNR) from India?

It is very easy for Indian residents to invest directly in Burning Rock Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Burning Rock Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Burning Rock Biotech or BNR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Burning Rock Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Burning Rock Biotech shares which would translate to 0.157 fractional shares of Burning Rock Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Burning Rock Biotech, in just a few clicks!

Returns in Burning Rock Biotech (BNR) for Indian investors in Rupees

The Burning Rock Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Burning Rock Biotech investment value today

Current value as on today

₹74,213

Returns

₹25,787

(-25.79%)

Returns from Burning Rock Biotech Stock

₹30,750 (-30.75%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Burning Rock Biotech (BNR)

-8%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Burning Rock Biotech Stock from India on INDmoney has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Burning Rock Biotech

Kynam Capital Management, LP
9.70%
Massachusetts Financial Services Company
3.65%
CRCM LP
3.18%
Fidelity International Ltd
2.74%
Millennium Management LLC
1.42%
Sumitomo Mitsui Trust Group Inc
0.50%

Analyst Recommendation on Burning Rock Biotech

Buy

80%Buy

20%Hold

0%Sell

Based on 5 Wall street analysts offering stock ratings for Burning Rock Biotech(by analysts ranked 0 to 5 stars)

Based on 5 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Burning Rock Biotech Stock (BNR)

What analysts predicted

Downside of 27.26%

Target:

$4.03

Current:

$5.54

Insights on Burning Rock Biotech Stock (Ticker Symbol: BNR)

Price Movement
In the last 7 days, BNR stock has moved down by -18.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 135.53M → 128.64M (in $), with an average decrease of 5.1% per quarter
Increasing Net Profit
Netprofit is up for the last 7 quarters, -216.22M → -35.74M (in $), with an average increase of 46.6% per quarter
BNR vs TMO (1 yr)
In the last 1 year, Burning Rock Biotech Ltd has experienced a drawdown of -34.7%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 23.1%
BNR vs TMO (3 yr)
In the last 3 years, Burning Rock Biotech Ltd has experienced a drawdown of -93.0%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 87.4%
Price to Sales
ForBNR every $1 of sales, investors are willing to pay $0.1, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.6 for every $1 of sales.

BNR Burning Rock Biotech Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.3M	↑ 87.89%
Net Income	$-25.8M	↑ 35.21%
Net Profit Margin	-84.98%	↑ 33.11%

	FY19	Y/Y Change
Revenue	$54.4M	↑ 82.74%
Net Income	$-24.0M	↓ 5.16%
Net Profit Margin	-44.1%	↑ 40.88%

	FY20	Y/Y Change
Revenue	$65.7M	↑ 12.64%
Net Income	$-57.1M	↑ 122.0%
Net Profit Margin	-86.93%	↓ 42.83%

	FY21	Y/Y Change
Revenue	$79.7M	↑ 18.13%
Net Income	$-125.1M	↑ 113.19%
Net Profit Margin	-156.87%	↓ 69.94%

	FY22	Y/Y Change
Revenue	$80.7M	↑ 10.9%
Net Income	$-139.2M	↑ 21.91%
Net Profit Margin	-172.44%	↓ 15.57%

	FY23	Y/Y Change
Revenue	$75.3M	↓ 4.58%
Net Income	$-91.5M	↓ 32.69%
Net Profit Margin	-121.63%	↑ 50.81%

	Q2 FY23	Q/Q Change
Revenue	$17.8M	↓ 10.31%
Net Income	$-24.4M	↓ 19.07%
Net Profit Margin	-137.17%	↑ 14.85%

	Q3 FY23	Q/Q Change
Revenue	$16.6M	↓ 5.08%
Net Income	$-22.2M	↓ 7.3%
Net Profit Margin	-133.97%	↑ 3.2%

	Q4 FY23	Q/Q Change
Revenue	$17.6M	↑ 3.75%
Net Income	$-17.0M	↓ 25.07%
Net Profit Margin	-96.76%	↑ 37.21%

	Q1 FY24	Q/Q Change
Revenue	$18.8M	↑ 7.89%
Net Income	$-15.0M	↓ 11.12%
Net Profit Margin	-79.71%	↑ 17.05%

	Q2 FY24	Q/Q Change
Revenue	$18.7M	↑ 0.0%
Net Income	$-14.9M	↑ 0.0%
Net Profit Margin	-79.71%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$128.6M	↓ 5.08%
Net Income	$-35.7M	↓ 66.91%
Net Profit Margin	-27.79%	↑ 51.92%

	FY18	Y/Y Change
Profit	$19.6M	↑ 88.38%

	FY19	Y/Y Change
Profit	$39.0M	↑ 102.38%

	FY20	Y/Y Change
Profit	$48.0M	↑ 14.85%

	FY21	Y/Y Change
Profit	$57.2M	↑ 16.0%

	FY22	Y/Y Change
Profit	$54.5M	↑ 4.36%

	FY23	Y/Y Change
Profit	$50.9M	↓ 4.42%

	Q2 FY23	Q/Q Change
Profit	$12.0M	↓ 15.15%

	Q3 FY23	Q/Q Change
Profit	$10.7M	↓ 9.09%

	Q4 FY23	Q/Q Change
Profit	$12.0M	↑ 9.71%

	Q1 FY24	Q/Q Change
Profit	$13.3M	↑ 11.37%

	Q2 FY24	Q/Q Change
Profit	$13.2M	↑ 0.0%

	Q3 FY24	Q/Q Change
Profit	$91.8M	↓ 3.76%

	FY18	Y/Y Change
Operating Cash Flow	$-21.6M	↑ 11.28%
Investing Cash Flow	$15.4M	↓ 155.52%
Financing Cash Flow	$12.1M	↓ 76.45%

	FY19	Y/Y Change
Operating Cash Flow	$-32.5M	↑ 53.27%
Investing Cash Flow	$-49.4M	↓ 426.76%
Financing Cash Flow	$81.5M	↑ 585.59%

	FY20	Y/Y Change
Operating Cash Flow	$-11.2M	↓ 67.75%
Investing Cash Flow	$-16.7M	↓ 68.47%
Financing Cash Flow	$331.1M	↑ 278.8%

	FY21	Y/Y Change
Operating Cash Flow	$-75.0M	↑ 549.8%
Investing Cash Flow	$12.8M	↓ 174.74%
Financing Cash Flow	$-8.3M	↓ 102.44%

	FY22	Y/Y Change
Operating Cash Flow	$-65.5M	↓ 4.41%
Investing Cash Flow	$-1.1M	↓ 109.13%
Financing Cash Flow	$-12.4M	↑ 63.02%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-6.6M	↓ 29.97%
Investing Cash Flow	$-408.8K	↓ 27.86%
Financing Cash Flow	$-6.4M	↑ 355.51%

Burning Rock Biotech Technicals Summary

Sell

Neutral

Buy

Burning Rock Biotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Burning Rock Biotech (BNR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Burning Rock Biotech Ltd	-19.63%	11.12%	-34.7%	-92.75%	-97.88%
Agilent Technologies Inc.	-16.31%	-11.06%	-15.84%	-5.59%	73.94%
Idexx Laboratories, Inc.	-5.04%	-5.88%	-20.78%	-14.63%	81.86%
Thermo Fisher Scientific, Inc.	-11.02%	-14.88%	-12.67%	-3.4%	74.9%
Danaher Corp.	-4.23%	-22.21%	-18.58%	-21.71%	45.43%
Iqvia Holdings Inc.	-8.23%	-26.02%	-27.43%	-15.27%	48.04%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Burning Rock Biotech Ltd	NA	NA	NA	0.0	-0.57	-0.26	NA	62.79
Agilent Technologies Inc.	28.22	28.22	2.06	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	40.97	40.97	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.62	31.62	2.05	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.81	38.81	2.07	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.51	24.51	0.99	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Burning Rock Biotech Ltd	Buy	$61.7M	-97.88%	NA	-83.69%
Agilent Technologies Inc.	Buy	$35.1B	73.94%	28.22	19.27%
Idexx Laboratories, Inc.	Buy	$35.6B	81.86%	40.97	22.78%
Thermo Fisher Scientific, Inc.	Buy	$197.5B	74.9%	31.62	14.77%
Danaher Corp.	Buy	$147.0B	45.43%	38.81	16.33%
Iqvia Holdings Inc.	Buy	$32.4B	48.04%	24.51	8.91%

About Burning Rock Biotech

Burning Rock Biotech Limited primarily develops and sells cancer therapy selection tests in the People's Republic of China. It operates through three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. The company also provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients, as well as Magnis BR-customized version of its principal products. In addition, it offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. The company was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.

Organization	Burning Rock Biotech
Employees	786
CEO	Mr. Yusheng Han
Industry	Health Services

Management People of Burning Rock Biotech

Name	Title
Mr. Yusheng Han	Founder, Chairman & CEO
Ms. Xiaozhi Hu	Senior Director of Finance
Dr. Zhihong Zhang	CTO & Director
Mr. Hao Liu	Senior Advisor

Important FAQs about investing in BNR Stock from India :

What is Burning Rock Biotech share price today?

Burning Rock Biotech share price today stands at $5.54, Open: $5.22 ; Previous Close: $5.22 ; High: $5.54 ; Low: $5.22 ; 52 Week High: $8.99 ; 52 Week Low: $2.62.

The stock opens at $5.22, after a previous close of $5.22. The stock reached a daily high of $5.54 and a low of $5.22, with a 52-week high of $8.99 and a 52-week low of $2.62.

Can Indians buy Burning Rock Biotech shares?

Yes, Indians can invest in the Burning Rock Biotech (BNR) from India.

With INDmoney, you can buy Burning Rock Biotech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Burning Rock Biotech at zero transaction cost.

How can I buy Burning Rock Biotech shares from India?

It is very easy to buy Burning Rock Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Burning Rock Biotech (BNR) be purchased?

Yes, you can buy fractional shares of Burning Rock Biotech with INDmoney app.

What are the documents required to start investing in Burning Rock Biotech stocks?

To start investing in Burning Rock Biotech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.